Our findings correlate well with a recent report that identified CHK1 as being over-expressed in TNBCs and that p53 expression does not directly effect CHK1 expression [31] suggesting that CHK1 is a valid TNBC target, distinct from other non-tumor cells. This evidence concerns the gene CHEK1 and neoplasm.